SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand

Investing.com Gold reports: SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand. Full body text was unavailable at ingest time, so this brief is based on headline context.